World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
61
Citations
24811
World Ranking
3597
National Ranking
1659

Bradley S. Galer publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Bradley S. Galer sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 179 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Bradley S. Galer D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Bradley S. Galer sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 61 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Bradley S. Galer is affiliated with Endo Pharmaceuticals in the United States and has an extensive publication record primarily in the field of medicine. Their work spans multiple subfields including psychiatry and mental health, pediatrics, perinatology and child health, cardiology and cardiovascular medicine, molecular biology, and cellular and molecular neuroscience.

The primary focus of their research centers on epilepsy research and treatment, with significant contributions also made to pharmacological effects and toxicity studies. Other main topics in their work include neuroscience and neuropharmacology research, neonatal and fetal brain pathology, heart failure treatment and management, pharmacological receptor mechanisms and effects, and cardiac arrhythmias and treatments.

Frequent publication venues for their work include:

  • Neurology
  • Epilepsy & Behavior
  • Epilepsia
  • European Journal of Paediatric Neurology
  • PsycTESTS Dataset

Bradley S. Galer has collaborated regularly with several coauthors, including:

  • Arnold R. Gammaitoni (31 publications)
  • Gail Farfel (19 publications)
  • Joseph Sullivan (15 publications)
  • Rima Nabbout (12 publications)
  • Anupam Agarwal (11 publications)

Their recent notable papers include:

  • Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome, 2022, published in JAMA Neurology
  • Fenfluramine acts as a positive modulator of sigma-1 receptors, 2020, published in Epilepsy & Behavior
  • Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome, 2021, published in Seizure
  • Fenfluramine HCl (Fintepla®) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension study, 2020, published in Epilepsia
  • Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome, 2021, published in Epilepsy & Behavior

Best Publications

  • Topical Review and RecommendationsCore outcome measures for chronic pain clinical trials: IMMPACT recommendations

    Robert H. Dworkin;Dennis C. Turk;John T. Farrar;Jennifer A. Haythornthwaite

  • Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.

    Dennis C Turk;Robert H Dworkin;Robert R Allen;Nicholas Bellamy

  • Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations

    Robert H. Dworkin;Miroslav Backonja;Michael C. Rowbotham;Robert R. Allen

  • Development and preliminary validation of a pain measure specific to neuropathic pain The Neuropathic Pain Scale

    Bradley S. Galer;Mark P. Jensen

  • Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life.

    Bradley S. Galer;Ann Gianas;Mark P. Jensen

  • External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria

    Stephen Bruehl;Robert N Harden;Bradley S. Galer;Samuel Saltz

  • Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

    Michael C. Rowbotham;Pamela S. Davies;Christina Verkempinck;Bradley S. Galer

  • Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

    Bradley S Galer;Michael C Rowbotham;Jill Perander;Erika Friedman

  • Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive?

    R. Norman Harden;Stephen Bruehl;Bradley S. Galer;Samuel Saltz

  • Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients.

    Ginger Allen;Bradley S. Galer;Lauren Schwartz

  • Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome?

    Stephen Bruehl;R Norman Harden;Bradley S Galer;Samuel Saltz

  • Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

    L Lagae;J Sullivan;K Knupp;L Laux

  • Neglect-Like Symptoms in Complex Regional Pain Syndrome: Results of a Self-Administered Survey

    Bradley S Galer;Mark Jensen

  • The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.

    Bradley S. Galer;Mark P. Jensen;Tina Ma;Pamela S. Davies

  • Individual variability in the response to different opioids: report of five cases☆

    Bradley S. Galer;Nessa Coyle;Gavril W. Pasternak;Russell K. Portenoy

  • Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study.

    Allison Devers;Bradley S. Galer

  • Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.

    Arnold R. Gammaitoni;Nancy A. Alvarez;Bradley S. Galer

  • Neuropathic pain of peripheral origin: advances in pharmacologic treatment.

    Bradley S. Galer

  • Case reports and hypothesis: A neglect-like syndrome may be responsible for the motor disturbance in reflex sympathetic dystrophy (complex regional pain syndrome-1)

    Bradley S. Galer;Stephen Butler;Mark P. Jensen

  • Review of Lidocaine Patch 5% Studies in the Treatment of Postherpetic Neuralgia

    Pamela S Davies;Bradley S Galer;Bradley S Galer

  • Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Editorial

    Robert H. Dworkin;Miroslav Backonja;Michael C. Rowbotham;Robert R. Allen

Frequent Co-Authors

Mark P. Jensen
Mark P. Jensen University of Washington
Lieven Lagae
Lieven Lagae KU Leuven
Joseph Sullivan
Joseph Sullivan University of California, San Francisco
Robert H. Dworkin
Robert H. Dworkin University of Rochester Medical Center
Berten Ceulemans
Berten Ceulemans University of Antwerp
Rima Nabbout
Rima Nabbout Université Paris Cité
Orrin Devinsky
Orrin Devinsky New York University
Antonio Gil-Nagel
Antonio Gil-Nagel Hospital Ruber Internacional
Richard B. Lipton
Richard B. Lipton Albert Einstein College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Bradley S. Galer

Trending Scientists

Recently Published Articles